Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.030
-0.020 (-0.66%)
Nov 16, 2026, 4:00 PM EST - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 226 employees as of December 31, 2025. The number of employees increased by 13 or 6.10% compared to the previous year. That makes Protalix BioTherapeutics the 25,945th largest employer in the world and 3,285th in the United States.
Employees
226
Change (1Y)
13
Growth (1Y)
6.10%
Revenue / Employee
$374,748
Profits / Employee
$90,934
Market Cap
255.49M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 226 | 13 | 6.10% | 226 | 0 |
| Dec 31, 2024 | 213 | 5 | 2.40% | 213 | 0 |
| Dec 31, 2023 | 208 | 11 | 5.58% | 208 | 0 |
| Dec 31, 2022 | 197 | -9 | -4.37% | 193 | 4 |
| Dec 31, 2021 | 206 | -1 | -0.48% | 202 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Cabaletta Bio | 158 |
| Ocugen | 116 |
| Inovio Pharmaceuticals | 112 |
| Arcturus Therapeutics Holdings | 111 |
| Lexeo Therapeutics | 63 |
| Camp4 Therapeutics | 48 |
| Faeth Therapeutics | 29 |
PLX News
- 6 days ago - Protalix BioTherapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 6 days ago - Protalix BioTherapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - Protalix BioTherapeutics Earnings release: Q3 2026 - Filings
- 6 days ago - Protalix BioTherapeutics Quarterly report: Q3 2026 - Filings
- 6 days ago - Protalix BioTherapeutics Slides: Corporate presentation - Filings
- 6 days ago - Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results - PRNewsWire
- 7 days ago - Protalix announces individual participant results from PRX-115 study - TheFly
- 7 days ago - Higher Single PRX-115 Doses Kept Plasma Uric Acid Levels Below Therapeutic Target for Longer Durations - PRNewsWire